Amdoxovir
Amdoxovir (DAPD) is an orally active nucleoside reverse transcriptase inhibitor. Amdoxovir is active against wild-type and NRTl-resistant viruses. Amdoxovir is the prodrug of dioxolane guanosine. Amdoxovir can be used for research of HIV/AIDS[1].
Product Specifications
CAS Number
145514-04-1
Product Name Alternative
DAPD
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
HIV; Reverse Transcriptase
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/amdoxovir.html
Smiles
NC1=C2C(N([C@@H]3O[C@@H](OC3)CO)C=N2)=NC(N)=N1
Molecular Formula
C9H12N6O3
Molecular Weight
252.23
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Gripshover BM, et al. Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118) . Antivir Ther. 2006;11 (5) :619-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog